Results 91 to 100 of about 1,643 (175)

Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. [PDF]

Proc Natl Acad Sci U S A
Miotto MC, Luna-Figueroa E, Tchagou C, Bahlouli L, Reiken S, Dridi H, Liu Y, Weninger G, Marks AR.   +8 more
europepmc   +1 more source

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response [PDF]

, 2013
James Yun, Jonas Mattsson, Klara Schnyder, Stefano Fontana, Carlo R. Largiadèr, Werner J. Pichler, Daniel Yerly   +6 more
openalex   +1 more source

Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review. [PDF]

J Nephrol
Kamel NA, Stokes MA, Wright DFB, Sud K, Tarafdar S, Castelino RL, Stocker SL.   +6 more
europepmc   +1 more source

Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions [PDF]

, 2015
Wen‐Hung Chung, Ren‐You Pan, Mu-Tzu Chu, See-Wen Chin, Yu-Lin Huang, Wei-Chi Wang, Jen‐Yun Chang, Wen‐Hung Chung   +7 more
openalex   +1 more source

FARFOOD: a database of potential interactions between food compounds and drugs. [PDF]

BioData Min
Nevado-Bulnes AM, Benitez DA, Cumplido-Laso G, Carvajal-González JM, Mulero-Navarro S, Román AC.   +5 more
europepmc   +1 more source

Impact of Oxypurinol in Patients With Symptomatic Heart Failure

Journal of the American College of Cardiology, 2008
Hare, Joshua M., Mangal, Brian, Brown, Joanne, Fisher Jr, Charles, Freudenberger, Ronald, Colucci, Wilson S., Mann, Douglas L., Liu, Peter, Givertz, Michael M., Schwarz, Richard P.   +9 more
openaire   +1 more source

A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level. [PDF]

Pharmacogenomics
A Zairol Azwan FA, Teo YY, Mohd Tahir NA, Saffian SM, Makmor-Bakry M, Mohamed Said MS.   +5 more
europepmc   +1 more source

Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk. [PDF]

PLoS One, 2023
Feaver RE, Bowers MS, Cole BK, Hoang S, Lawson MJ, Taylor J, LaMoreaux BD, Zhao L, Henke BR, Johns BA, Nyborg AC, Wamhoff BR, Figler RA.   +12 more
europepmc   +1 more source

Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol. [PDF]

Rheumatology (Oxford)
Fanning NC, Cadzow M, Topless RK, Frampton C, Dalbeth N, Merriman TR, Stamp LK.   +6 more
europepmc   +1 more source

Mechanism of xanthine oxidase in flap ischemia-reperfusion injury and advances in targeted therapy: a mini review. [PDF]

Front Physiol
Jia W, Wei X, Gong X.
europepmc   +1 more source